Quinoline derivatives and their use as 5-HT6 ligands

Details for Australian Patent Application No. 2003219103 (hide)

Owner Glaxo Group Limited

Inventors Witty, David; Thompson, Mervyn; Johnson, Christopher Norbert; MacDonald, Gregor James; Wade, Charles Edward; Moss, Stephen Frederick; Ahmed, Mahmood; Jones, Martin C

Agent Davies Collison Cave

Pub. Number AU-B-2003219103

PCT Number PCT/EP03/03197

PCT Pub. Number WO2003/080580

Priority 0207289.0 27.03.02 GB; 0225678.2 04.11.02 GB

Filing date 25 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 23 October 2008

International Classifications

C07D 215/40 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 215/00 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 0207289.0 27.03.02 GB; 0225678.2 04.11.02 GB

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003219103

23 October 2008 Application Accepted

  Published as AU-B-2003219103

19 February 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219104-CONDUCTOR CROSSOVER FOR A SEMICONDUCTOR DETECTOR

2003219102-Combined therapy against tumors comprising subtituted acryloyl distamycin derivatives and radiotherapy